Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.

Adenoviruses are common pathogens, mostly targeting ocular, gastrointestinal and respiratory cells, but in some cases infection disseminates, presenting in severe clinical outcomes. Upon dissemination and contact with blood, coagulation factor X (FX) interacts directly with the adenovirus type 5 (Ad...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiangtao Ma, Margaret R Duffy, Lin Deng, Rachel S Dakin, Taco Uil, Jerome Custers, Sharon M Kelly, John H McVey, Stuart A Nicklin, Andrew H Baker
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-02-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1004673
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332306485968896
author Jiangtao Ma
Margaret R Duffy
Lin Deng
Rachel S Dakin
Taco Uil
Jerome Custers
Sharon M Kelly
John H McVey
Stuart A Nicklin
Andrew H Baker
author_facet Jiangtao Ma
Margaret R Duffy
Lin Deng
Rachel S Dakin
Taco Uil
Jerome Custers
Sharon M Kelly
John H McVey
Stuart A Nicklin
Andrew H Baker
author_sort Jiangtao Ma
collection DOAJ
description Adenoviruses are common pathogens, mostly targeting ocular, gastrointestinal and respiratory cells, but in some cases infection disseminates, presenting in severe clinical outcomes. Upon dissemination and contact with blood, coagulation factor X (FX) interacts directly with the adenovirus type 5 (Ad5) hexon. FX can act as a bridge to bind heparan sulphate proteoglycans, leading to substantial Ad5 hepatocyte uptake. FX "coating" also protects the virus from host IgM and complement-mediated neutralisation. However, the contribution of FX in determining Ad liver transduction whilst simultaneously shielding the virus from immune attack remains unclear. In this study, we demonstrate that the FX protection mechanism is not conserved amongst Ad types, and identify the hexon hypervariable regions (HVR) of Ad5 as the capsid proteins targeted by this host defense pathway. Using genetic and pharmacological approaches, we manipulate Ad5 HVR interactions to interrogate the interplay between viral cell transduction and immune neutralisation. We show that FX and inhibitory serum components can co-compete and virus neutralisation is influenced by both the location and extent of modifications to the Ad5 HVRs. We engineered Ad5-derived HVRs into the rare, native non FX-binding Ad26 to create Ad26.HVR5C. This enabled the virus to interact with FX at high affinity, as quantified by surface plasmon resonance, FX-mediated cell binding and transduction assays. Concomitantly, Ad26.HVR5C was also sensitised to immune attack in the absence of FX, a direct consequence of the engineered HVRs from Ad5. In both immune competent and deficient animals, Ad26.HVR5C hepatic gene transfer was mediated by FX following intravenous delivery. This study gives mechanistic insight into the pivotal role of the Ad5 HVRs in conferring sensitivity to virus neutralisation by IgM and classical complement-mediated attack. Furthermore, through this gain-of-function approach we demonstrate the dual functionality of FX in protecting Ad26.HVR5C against innate immune factors whilst determining liver targeting.
format Article
id doaj-art-6ac6df5e8e0a463095cf3f42d8085f51
institution Kabale University
issn 1553-7366
1553-7374
language English
publishDate 2015-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-6ac6df5e8e0a463095cf3f42d8085f512025-08-20T03:46:13ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742015-02-01112e100467310.1371/journal.ppat.1004673Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.Jiangtao MaMargaret R DuffyLin DengRachel S DakinTaco UilJerome CustersSharon M KellyJohn H McVeyStuart A NicklinAndrew H BakerAdenoviruses are common pathogens, mostly targeting ocular, gastrointestinal and respiratory cells, but in some cases infection disseminates, presenting in severe clinical outcomes. Upon dissemination and contact with blood, coagulation factor X (FX) interacts directly with the adenovirus type 5 (Ad5) hexon. FX can act as a bridge to bind heparan sulphate proteoglycans, leading to substantial Ad5 hepatocyte uptake. FX "coating" also protects the virus from host IgM and complement-mediated neutralisation. However, the contribution of FX in determining Ad liver transduction whilst simultaneously shielding the virus from immune attack remains unclear. In this study, we demonstrate that the FX protection mechanism is not conserved amongst Ad types, and identify the hexon hypervariable regions (HVR) of Ad5 as the capsid proteins targeted by this host defense pathway. Using genetic and pharmacological approaches, we manipulate Ad5 HVR interactions to interrogate the interplay between viral cell transduction and immune neutralisation. We show that FX and inhibitory serum components can co-compete and virus neutralisation is influenced by both the location and extent of modifications to the Ad5 HVRs. We engineered Ad5-derived HVRs into the rare, native non FX-binding Ad26 to create Ad26.HVR5C. This enabled the virus to interact with FX at high affinity, as quantified by surface plasmon resonance, FX-mediated cell binding and transduction assays. Concomitantly, Ad26.HVR5C was also sensitised to immune attack in the absence of FX, a direct consequence of the engineered HVRs from Ad5. In both immune competent and deficient animals, Ad26.HVR5C hepatic gene transfer was mediated by FX following intravenous delivery. This study gives mechanistic insight into the pivotal role of the Ad5 HVRs in conferring sensitivity to virus neutralisation by IgM and classical complement-mediated attack. Furthermore, through this gain-of-function approach we demonstrate the dual functionality of FX in protecting Ad26.HVR5C against innate immune factors whilst determining liver targeting.https://doi.org/10.1371/journal.ppat.1004673
spellingShingle Jiangtao Ma
Margaret R Duffy
Lin Deng
Rachel S Dakin
Taco Uil
Jerome Custers
Sharon M Kelly
John H McVey
Stuart A Nicklin
Andrew H Baker
Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
PLoS Pathogens
title Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
title_full Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
title_fullStr Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
title_full_unstemmed Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
title_short Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
title_sort manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor x dependent cell interaction in vitro and in vivo
url https://doi.org/10.1371/journal.ppat.1004673
work_keys_str_mv AT jiangtaoma manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT margaretrduffy manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT lindeng manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT rachelsdakin manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT tacouil manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT jeromecusters manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT sharonmkelly manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT johnhmcvey manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT stuartanicklin manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo
AT andrewhbaker manipulatingadenovirushexonhypervariableloopsdictatesimmuneneutralisationandcoagulationfactorxdependentcellinteractioninvitroandinvivo